Earnings Summary

Cardiovascular Systems Inc.’s revenue fell -99.9% since last year same period to $0.06Mn in the Q4 2022. On a quarterly growth basis, Cardiovascular Systems Inc. has generated -99.9% fall in its revenue since last 3-months.

Cardiovascular Systems Inc.’s net profit jumped 99.91% since last year same period to $-0.01Mn in the Q4 2022. On a quarterly growth basis, Cardiovascular Systems Inc. has generated 99.93% jump in its net profits since last 3-months.

Cardiovascular Systems Inc.’s net profit margin jumped 15.35% since last year same period to -12.84% in the Q4 2022. On a quarterly growth basis, Cardiovascular Systems Inc. has generated 27.95% jump in its net profit margins since last 3-months.

Cardiovascular Systems Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.15 - a 34.78% jump from last quarter’s estimates.

Cardiovascular Systems Inc.’s earning per share (EPS) estimates for the current year stand at -0.15.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Cardiovascular Systems Inc.’s return on assets (ROA) stands at -0.08.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Cardiovascular Systems Inc.’s return on equity (ROE) stands at -0.15.